Literature DB >> 16537913

Cell-specific metabolism and pathogenesis of transmembrane prion protein.

Yaping Gu1, Xiu Luo, Subhabrata Basu, Hisashi Fujioka, Neena Singh.   

Abstract

The C-transmembrane form of prion protein ((Ctm)PrP) has been implicated in prion disease pathogenesis, but the factors underlying its biogenesis and cyotoxic potential remain unclear. Here we show that (Ctm)PrP interferes with cytokinesis in cell lines where it is transported to the plasma membrane. These cells fail to separate following cell division, assume a variety of shapes and sizes, and contain multiple nuclei, some of which are pyknotic. Furthermore, the synthesis and transport of (Ctm)PrP to the plasma membrane are modulated through a complex interaction between cis- and trans-acting factors and the endoplasmic reticulum translocation machinery. Thus, insertion of eight amino acids before or within the N region of the N signal peptide (N-SP) of PrP results in the exclusive synthesis of (Ctm)PrP regardless of the charge conferred to the N region. Subsequent processing and transport of (Ctm)PrP are modulated by specific amino acids in the N region of the N-SP and by the cell line of expression. Although the trigger for (Ctm)PrP upregulation in naturally occurring prion disorders remains elusive, these data highlight the underlying mechanisms of (Ctm)PrP biogenesis and neurotoxicity and reinforce the idea that (Ctm)PrP may serve as the proximate cause of neuronal death in certain prion disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16537913      PMCID: PMC1430324          DOI: 10.1128/MCB.26.7.2697-2715.2006

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  35 in total

1.  Incomplete cytokinesis and induction of apoptosis by overexpression of the mammalian polo-like kinase, Plk3.

Authors:  C W Conn; R F Hennigan; W Dai; Y Sanchez; P J Stambrook
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

2.  A transmembrane form of the prion protein contains an uncleaved signal peptide and is retained in the endoplasmic Reticulum.

Authors:  R S Stewart; B Drisaldi; D A Harris
Journal:  Mol Biol Cell       Date:  2001-04       Impact factor: 4.138

3.  The prion protein has DNA strand transfer properties similar to retroviral nucleocapsid protein.

Authors:  C Gabus; S Auxilien; C Péchoux; D Dormont; W Swietnicki; M Morillas; W Surewicz; P Nandi; J L Darlix
Journal:  J Mol Biol       Date:  2001-04-06       Impact factor: 5.469

4.  Signal sequences control gating of the protein translocation channel in a substrate-specific manner.

Authors:  Soo Jung Kim; Devarati Mitra; Jeffrey R Salerno; Ramanujan S Hegde
Journal:  Dev Cell       Date:  2002-02       Impact factor: 12.270

5.  Combinatorial control of prion protein biogenesis by the signal sequence and transmembrane domain.

Authors:  S J Kim; R Rahbar; R S Hegde
Journal:  J Biol Chem       Date:  2001-05-18       Impact factor: 5.157

6.  Prion protein contains a second endoplasmic reticulum targeting signal sequence located at its C terminus.

Authors:  C Hölscher; U C Bach; B Dobberstein
Journal:  J Biol Chem       Date:  2001-01-22       Impact factor: 5.157

7.  A transmembrane form of the prion protein is localized in the Golgi apparatus of neurons.

Authors:  Richard S Stewart; David A Harris
Journal:  J Biol Chem       Date:  2005-01-25       Impact factor: 5.157

8.  Prion peptide 106-126 modulates the aggregation of cellular prion protein and induces the synthesis of potentially neurotoxic transmembrane PrP.

Authors:  Yaping Gu; Hisashi Fujioka; Ravi Shankar Mishra; Ruliang Li; Neena Singh
Journal:  J Biol Chem       Date:  2001-10-26       Impact factor: 5.157

9.  Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol.

Authors:  Jiyan Ma; Robert Wollmann; Susan Lindquist
Journal:  Science       Date:  2002-10-17       Impact factor: 47.728

10.  Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress.

Authors:  K Haze; H Yoshida; H Yanagi; T Yura; K Mori
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

View more
  5 in total

Review 1.  Redox control of prion and disease pathogenesis.

Authors:  Neena Singh; Ajay Singh; Dola Das; Maradumane L Mohan
Journal:  Antioxid Redox Signal       Date:  2010-06-01       Impact factor: 8.401

2.  Cytosolic prion protein is the predominant anti-Bax prion protein form: exclusion of transmembrane and secreted prion protein forms in the anti-Bax function.

Authors:  David T S Lin; Julie Jodoin; Michaël Baril; Cynthia G Goodyer; Andréa C Leblanc
Journal:  Biochim Biophys Acta       Date:  2008-06-06

Review 3.  Iron in neurodegenerative disorders of protein misfolding: a case of prion disorders and Parkinson's disease.

Authors:  Neena Singh; Swati Haldar; Ajai K Tripathi; Matthew K McElwee; Katharine Horback; Amber Beserra
Journal:  Antioxid Redox Signal       Date:  2014-02-27       Impact factor: 8.401

4.  Pathogenic mutations in the glycosylphosphatidylinositol signal peptide of PrP modulate its topology in neuroblastoma cells.

Authors:  Yaping Gu; Ajay Singh; Sharmila Bose; Neena Singh
Journal:  Mol Cell Neurosci       Date:  2008-01-26       Impact factor: 4.314

5.  Alterations in the brain interactome of the intrinsically disordered N-terminal domain of the cellular prion protein (PrPC) in Alzheimer's disease.

Authors:  Sarah Ulbrich; Petra Janning; Ralf Seidel; Jakob Matschke; Anika Gonsberg; Sebastian Jung; Markus Glatzel; Martin Engelhard; Konstanze F Winklhofer; Jörg Tatzelt
Journal:  PLoS One       Date:  2018-05-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.